Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Li

Showing results (41-50 of 206) with videos related to

Pageof 21
Sort By:
Urology|September 9, 2018
Detection and Treatment of Primary Prostatic MelanomaRoger Li, Miao Zhang, Jonathan J Duplisea, et al.
European Urology Oncology|November 4, 2024
Reply to Wen-Wei Sung's Letter to the Editor re: Wei Shen Tan, Ian M. McElree, Facundo Davaro, et al. Sequential Intravesical Gemcitabine and Docetaxel Is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non-muscle-invasive Bladder Cancer. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.06.011Wei Shen Tan, Michael O'Donnell, Roger Li, et al.
Urologic Oncology|April 15, 2023
Heterogeneity of BCG unresponsive bladder cancer clinical trials limits patients' access to novel therapeuticsMichael Chandra, Roger Li, Anil Parwani, et al.
Nature Reviews. Urology|June 29, 2021
Using oncolytic viruses to ignite the tumour immune microenvironment in bladder cancerRoger Li, Jingsong Zhang, Scott M Gilbert, et al.
European Urology Open Science|July 23, 2025
Local Therapy of the Primary Tumor: An Option for Metastatic Urothelial Carcinoma in the Era of Novel Combination Therapies?Renate Pichler, José Daniel Subiela, Roman Mayr, et al.
Current Opinion in Urology|January 4, 2021
Immunotherapy in Bacillus Calmette-Guerin (BCG) unresponsive nonmuscle invasive bladder cancerLee A Hugar, Scott M Gilbert, Wade J Sexton, et al.
Investigative and Clinical Urology|December 21, 2016
Current technique and results for extended pelvic lymph node dissection during robot-assisted radical prostatectomyRoger Li, Firas G Petros, Janet B Kukreja, et al.
F1000Research|January 21, 2017
New discoveries in the molecular landscape of bladder cancerRoger Li, Woonyoung Choi, J E Ferguson Rd, et al.
Current Opinion in Urology|November 12, 2024
Gold standard nephroureterectomy, chemoprophylaxis and surveillance in upper tract urothelial carcinomaGiuseppe Basile, Marco Bandini, Roger Li, et al.
BMC Bioinformatics|April 17, 2016
UNDR ROVER - a fast and accurate variant caller for targeted DNA sequencingDaniel J Park, Roger Li, Edmund Lau, et al.
Pageof 21

Showing results (41-50 of 206) with videos related to

Sort By:
Pageof 21
Urology|September 9, 2018
Detection and Treatment of Primary Prostatic MelanomaRoger Li, Miao Zhang, Jonathan J Duplisea, et al.
European Urology Oncology|November 4, 2024
Reply to Wen-Wei Sung's Letter to the Editor re: Wei Shen Tan, Ian M. McElree, Facundo Davaro, et al. Sequential Intravesical Gemcitabine and Docetaxel Is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non-muscle-invasive Bladder Cancer. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.06.011Wei Shen Tan, Michael O'Donnell, Roger Li, et al.
Urologic Oncology|April 15, 2023
Heterogeneity of BCG unresponsive bladder cancer clinical trials limits patients' access to novel therapeuticsMichael Chandra, Roger Li, Anil Parwani, et al.
Nature Reviews. Urology|June 29, 2021
Using oncolytic viruses to ignite the tumour immune microenvironment in bladder cancerRoger Li, Jingsong Zhang, Scott M Gilbert, et al.
European Urology Open Science|July 23, 2025
Local Therapy of the Primary Tumor: An Option for Metastatic Urothelial Carcinoma in the Era of Novel Combination Therapies?Renate Pichler, José Daniel Subiela, Roman Mayr, et al.
Current Opinion in Urology|January 4, 2021
Immunotherapy in Bacillus Calmette-Guerin (BCG) unresponsive nonmuscle invasive bladder cancerLee A Hugar, Scott M Gilbert, Wade J Sexton, et al.
Investigative and Clinical Urology|December 21, 2016
Current technique and results for extended pelvic lymph node dissection during robot-assisted radical prostatectomyRoger Li, Firas G Petros, Janet B Kukreja, et al.
F1000Research|January 21, 2017
New discoveries in the molecular landscape of bladder cancerRoger Li, Woonyoung Choi, J E Ferguson Rd, et al.
Current Opinion in Urology|November 12, 2024
Gold standard nephroureterectomy, chemoprophylaxis and surveillance in upper tract urothelial carcinomaGiuseppe Basile, Marco Bandini, Roger Li, et al.
BMC Bioinformatics|April 17, 2016
UNDR ROVER - a fast and accurate variant caller for targeted DNA sequencingDaniel J Park, Roger Li, Edmund Lau, et al.
Pageof 21